nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2D6—Alzheimer's disease	0.185	0.544	CbGaD
Etoricoxib—PTGS2—Alzheimer's disease	0.155	0.456	CbGaD
Etoricoxib—CYP2D6—Rivastigmine—Alzheimer's disease	0.064	0.179	CbGbCtD
Etoricoxib—CYP2C19—Memantine—Alzheimer's disease	0.0583	0.164	CbGbCtD
Etoricoxib—CYP2C9—Donepezil—Alzheimer's disease	0.0559	0.157	CbGbCtD
Etoricoxib—CYP2D6—Donepezil—Alzheimer's disease	0.0511	0.143	CbGbCtD
Etoricoxib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0407	0.114	CbGbCtD
Etoricoxib—CYP2D6—Galantamine—Alzheimer's disease	0.033	0.0924	CbGbCtD
Etoricoxib—CYP3A4—Donepezil—Alzheimer's disease	0.0325	0.0912	CbGbCtD
Etoricoxib—CYP3A4—Galantamine—Alzheimer's disease	0.021	0.0588	CbGbCtD
Etoricoxib—MAPK14—blood vessel—Alzheimer's disease	0.00271	0.171	CbGeAlD
Etoricoxib—Celecoxib—CA4—Alzheimer's disease	0.00196	0.532	CrCbGaD
Etoricoxib—MAPK14—embryo—Alzheimer's disease	0.00162	0.102	CbGeAlD
Etoricoxib—MAPK14—forebrain—Alzheimer's disease	0.00143	0.0903	CbGeAlD
Etoricoxib—MAPK14—telencephalon—Alzheimer's disease	0.00131	0.083	CbGeAlD
Etoricoxib—Vemurafenib—CYP2D6—Alzheimer's disease	0.000828	0.225	CrCbGaD
Etoricoxib—PTGS2—blood vessel—Alzheimer's disease	0.000779	0.0492	CbGeAlD
Etoricoxib—MAPK14—nervous system—Alzheimer's disease	0.000776	0.049	CbGeAlD
Etoricoxib—MAPK14—central nervous system—Alzheimer's disease	0.000747	0.0472	CbGeAlD
Etoricoxib—MAPK14—cerebellum—Alzheimer's disease	0.00073	0.0461	CbGeAlD
Etoricoxib—MAPK14—brain—Alzheimer's disease	0.000593	0.0375	CbGeAlD
Etoricoxib—Celecoxib—CYP2D6—Alzheimer's disease	0.000487	0.132	CrCbGaD
Etoricoxib—PTGS2—embryo—Alzheimer's disease	0.000465	0.0294	CbGeAlD
Etoricoxib—PTGS2—forebrain—Alzheimer's disease	0.000411	0.026	CbGeAlD
Etoricoxib—CYP2E1—telencephalon—Alzheimer's disease	0.00041	0.0259	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—Alzheimer's disease	0.000409	0.111	CrCbGaD
Etoricoxib—PTGS2—telencephalon—Alzheimer's disease	0.000378	0.0239	CbGeAlD
Etoricoxib—CYP2D6—forebrain—Alzheimer's disease	0.000353	0.0223	CbGeAlD
Etoricoxib—CYP2D6—telencephalon—Alzheimer's disease	0.000325	0.0205	CbGeAlD
Etoricoxib—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000267	0.00144	CcSEcCtD
Etoricoxib—Renal failure—Memantine—Alzheimer's disease	0.000267	0.00144	CcSEcCtD
Etoricoxib—Palpitations—Galantamine—Alzheimer's disease	0.000267	0.00144	CcSEcCtD
Etoricoxib—Pharyngitis—Donepezil—Alzheimer's disease	0.000267	0.00144	CcSEcCtD
Etoricoxib—Myocardial infarction—Memantine—Alzheimer's disease	0.000266	0.00144	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000266	0.00144	CcSEcCtD
Etoricoxib—Infestation—Rivastigmine—Alzheimer's disease	0.000266	0.00143	CcSEcCtD
Etoricoxib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000266	0.00143	CcSEcCtD
Etoricoxib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000265	0.00143	CcSEcCtD
Etoricoxib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000265	0.00143	CcSEcCtD
Etoricoxib—Conjunctivitis—Memantine—Alzheimer's disease	0.000264	0.00142	CcSEcCtD
Etoricoxib—Urinary tract infection—Memantine—Alzheimer's disease	0.000264	0.00142	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000264	0.00142	CcSEcCtD
Etoricoxib—Urethral disorder—Donepezil—Alzheimer's disease	0.000263	0.00142	CcSEcCtD
Etoricoxib—Cough—Galantamine—Alzheimer's disease	0.000263	0.00142	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000262	0.00141	CcSEcCtD
Etoricoxib—Renal failure—Rivastigmine—Alzheimer's disease	0.000261	0.00141	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000261	0.0014	CcSEcCtD
Etoricoxib—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000261	0.0014	CcSEcCtD
Etoricoxib—Hypertension—Galantamine—Alzheimer's disease	0.000261	0.0014	CcSEcCtD
Etoricoxib—Haematuria—Memantine—Alzheimer's disease	0.000259	0.0014	CcSEcCtD
Etoricoxib—Visual impairment—Donepezil—Alzheimer's disease	0.000259	0.0014	CcSEcCtD
Etoricoxib—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000259	0.00139	CcSEcCtD
Etoricoxib—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000259	0.00139	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000257	0.00138	CcSEcCtD
Etoricoxib—Arthralgia—Galantamine—Alzheimer's disease	0.000257	0.00138	CcSEcCtD
Etoricoxib—Chest pain—Galantamine—Alzheimer's disease	0.000257	0.00138	CcSEcCtD
Etoricoxib—Epistaxis—Memantine—Alzheimer's disease	0.000256	0.00138	CcSEcCtD
Etoricoxib—Anxiety—Galantamine—Alzheimer's disease	0.000256	0.00138	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000255	0.00137	CcSEcCtD
Etoricoxib—Sinusitis—Memantine—Alzheimer's disease	0.000255	0.00137	CcSEcCtD
Etoricoxib—Haematuria—Rivastigmine—Alzheimer's disease	0.000254	0.00137	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000252	0.00135	CcSEcCtD
Etoricoxib—Dry mouth—Galantamine—Alzheimer's disease	0.000251	0.00135	CcSEcCtD
Etoricoxib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000251	0.00135	CcSEcCtD
Etoricoxib—Tinnitus—Donepezil—Alzheimer's disease	0.000251	0.00135	CcSEcCtD
Etoricoxib—Sinusitis—Rivastigmine—Alzheimer's disease	0.00025	0.00134	CcSEcCtD
Etoricoxib—Confusional state—Galantamine—Alzheimer's disease	0.000248	0.00134	CcSEcCtD
Etoricoxib—Haemoglobin—Memantine—Alzheimer's disease	0.000245	0.00132	CcSEcCtD
Etoricoxib—Hepatitis—Memantine—Alzheimer's disease	0.000244	0.00131	CcSEcCtD
Etoricoxib—Haemorrhage—Memantine—Alzheimer's disease	0.000244	0.00131	CcSEcCtD
Etoricoxib—Hallucination—Memantine—Alzheimer's disease	0.000243	0.00131	CcSEcCtD
Etoricoxib—Hypoaesthesia—Memantine—Alzheimer's disease	0.000243	0.00131	CcSEcCtD
Etoricoxib—Shock—Galantamine—Alzheimer's disease	0.000242	0.00131	CcSEcCtD
Etoricoxib—CYP2E1—nervous system—Alzheimer's disease	0.000242	0.0153	CbGeAlD
Etoricoxib—Pharyngitis—Memantine—Alzheimer's disease	0.000242	0.0013	CcSEcCtD
Etoricoxib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000242	0.0013	CcSEcCtD
Etoricoxib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000241	0.0013	CcSEcCtD
Etoricoxib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000241	0.0013	CcSEcCtD
Etoricoxib—Oedema peripheral—Memantine—Alzheimer's disease	0.00024	0.00129	CcSEcCtD
Etoricoxib—Arrhythmia—Donepezil—Alzheimer's disease	0.00024	0.00129	CcSEcCtD
Etoricoxib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00024	0.00129	CcSEcCtD
Etoricoxib—Connective tissue disorder—Memantine—Alzheimer's disease	0.00024	0.00129	CcSEcCtD
Etoricoxib—Skin disorder—Galantamine—Alzheimer's disease	0.000239	0.00129	CcSEcCtD
Etoricoxib—Urethral disorder—Memantine—Alzheimer's disease	0.000239	0.00129	CcSEcCtD
Etoricoxib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000239	0.00129	CcSEcCtD
Etoricoxib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000239	0.00129	CcSEcCtD
Etoricoxib—Hallucination—Rivastigmine—Alzheimer's disease	0.000238	0.00128	CcSEcCtD
Etoricoxib—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000238	0.00128	CcSEcCtD
Etoricoxib—Alopecia—Donepezil—Alzheimer's disease	0.000238	0.00128	CcSEcCtD
Etoricoxib—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000237	0.00128	CcSEcCtD
Etoricoxib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000236	0.00127	CcSEcCtD
Etoricoxib—Mental disorder—Donepezil—Alzheimer's disease	0.000235	0.00127	CcSEcCtD
Etoricoxib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000235	0.00127	CcSEcCtD
Etoricoxib—Visual impairment—Memantine—Alzheimer's disease	0.000235	0.00127	CcSEcCtD
Etoricoxib—Anorexia—Galantamine—Alzheimer's disease	0.000235	0.00127	CcSEcCtD
Etoricoxib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000235	0.00126	CcSEcCtD
Etoricoxib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000234	0.00126	CcSEcCtD
Etoricoxib—Malnutrition—Donepezil—Alzheimer's disease	0.000234	0.00126	CcSEcCtD
Etoricoxib—Erythema—Donepezil—Alzheimer's disease	0.000234	0.00126	CcSEcCtD
Etoricoxib—CYP2E1—central nervous system—Alzheimer's disease	0.000233	0.0147	CbGeAlD
Etoricoxib—Erythema multiforme—Memantine—Alzheimer's disease	0.000231	0.00124	CcSEcCtD
Etoricoxib—Flatulence—Donepezil—Alzheimer's disease	0.000231	0.00124	CcSEcCtD
Etoricoxib—Visual impairment—Rivastigmine—Alzheimer's disease	0.00023	0.00124	CcSEcCtD
Etoricoxib—Dysgeusia—Donepezil—Alzheimer's disease	0.000229	0.00123	CcSEcCtD
Etoricoxib—Eye disorder—Memantine—Alzheimer's disease	0.000228	0.00123	CcSEcCtD
Etoricoxib—CYP2E1—cerebellum—Alzheimer's disease	0.000228	0.0144	CbGeAlD
Etoricoxib—Tinnitus—Memantine—Alzheimer's disease	0.000228	0.00123	CcSEcCtD
Etoricoxib—Flushing—Memantine—Alzheimer's disease	0.000226	0.00122	CcSEcCtD
Etoricoxib—Cardiac disorder—Memantine—Alzheimer's disease	0.000226	0.00122	CcSEcCtD
Etoricoxib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000226	0.00122	CcSEcCtD
Etoricoxib—Muscle spasms—Donepezil—Alzheimer's disease	0.000225	0.00121	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000224	0.00121	CcSEcCtD
Etoricoxib—PTGS2—nervous system—Alzheimer's disease	0.000223	0.0141	CbGeAlD
Etoricoxib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000223	0.0012	CcSEcCtD
Etoricoxib—Insomnia—Galantamine—Alzheimer's disease	0.000223	0.0012	CcSEcCtD
Etoricoxib—Tinnitus—Rivastigmine—Alzheimer's disease	0.000223	0.0012	CcSEcCtD
Etoricoxib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000222	0.00119	CcSEcCtD
Etoricoxib—Flushing—Rivastigmine—Alzheimer's disease	0.000222	0.00119	CcSEcCtD
Etoricoxib—Angiopathy—Memantine—Alzheimer's disease	0.000221	0.00119	CcSEcCtD
Etoricoxib—Vision blurred—Donepezil—Alzheimer's disease	0.000221	0.00119	CcSEcCtD
Etoricoxib—Immune system disorder—Memantine—Alzheimer's disease	0.00022	0.00119	CcSEcCtD
Etoricoxib—Mediastinal disorder—Memantine—Alzheimer's disease	0.00022	0.00118	CcSEcCtD
Etoricoxib—Tremor—Donepezil—Alzheimer's disease	0.000219	0.00118	CcSEcCtD
Etoricoxib—Somnolence—Galantamine—Alzheimer's disease	0.000219	0.00118	CcSEcCtD
Etoricoxib—Arrhythmia—Memantine—Alzheimer's disease	0.000218	0.00117	CcSEcCtD
Etoricoxib—Dyspepsia—Galantamine—Alzheimer's disease	0.000217	0.00117	CcSEcCtD
Etoricoxib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000217	0.00117	CcSEcCtD
Etoricoxib—Anaemia—Donepezil—Alzheimer's disease	0.000216	0.00116	CcSEcCtD
Etoricoxib—Alopecia—Memantine—Alzheimer's disease	0.000216	0.00116	CcSEcCtD
Etoricoxib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00116	CcSEcCtD
Etoricoxib—Agitation—Donepezil—Alzheimer's disease	0.000215	0.00116	CcSEcCtD
Etoricoxib—PTGS2—central nervous system—Alzheimer's disease	0.000215	0.0136	CbGeAlD
Etoricoxib—Decreased appetite—Galantamine—Alzheimer's disease	0.000214	0.00115	CcSEcCtD
Etoricoxib—Mental disorder—Memantine—Alzheimer's disease	0.000214	0.00115	CcSEcCtD
Etoricoxib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000213	0.00115	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000213	0.00115	CcSEcCtD
Etoricoxib—Malnutrition—Memantine—Alzheimer's disease	0.000212	0.00114	CcSEcCtD
Etoricoxib—Fatigue—Galantamine—Alzheimer's disease	0.000212	0.00114	CcSEcCtD
Etoricoxib—Alopecia—Rivastigmine—Alzheimer's disease	0.000211	0.00114	CcSEcCtD
Etoricoxib—Constipation—Galantamine—Alzheimer's disease	0.000211	0.00113	CcSEcCtD
Etoricoxib—PTGS2—cerebellum—Alzheimer's disease	0.00021	0.0133	CbGeAlD
Etoricoxib—Flatulence—Memantine—Alzheimer's disease	0.000209	0.00113	CcSEcCtD
Etoricoxib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000209	0.00113	CcSEcCtD
Etoricoxib—Dysgeusia—Memantine—Alzheimer's disease	0.000208	0.00112	CcSEcCtD
Etoricoxib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000208	0.00112	CcSEcCtD
Etoricoxib—Erythema—Rivastigmine—Alzheimer's disease	0.000208	0.00112	CcSEcCtD
Etoricoxib—Flatulence—Rivastigmine—Alzheimer's disease	0.000205	0.0011	CcSEcCtD
Etoricoxib—Cough—Donepezil—Alzheimer's disease	0.000204	0.0011	CcSEcCtD
Etoricoxib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000204	0.0011	CcSEcCtD
Etoricoxib—Feeling abnormal—Galantamine—Alzheimer's disease	0.000203	0.00109	CcSEcCtD
Etoricoxib—Hypertension—Donepezil—Alzheimer's disease	0.000202	0.00109	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000201	0.00109	CcSEcCtD
Etoricoxib—Vision blurred—Memantine—Alzheimer's disease	0.0002	0.00108	CcSEcCtD
Etoricoxib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0002	0.00108	CcSEcCtD
Etoricoxib—Arthralgia—Donepezil—Alzheimer's disease	0.000199	0.00107	CcSEcCtD
Etoricoxib—Chest pain—Donepezil—Alzheimer's disease	0.000199	0.00107	CcSEcCtD
Etoricoxib—Tremor—Memantine—Alzheimer's disease	0.000199	0.00107	CcSEcCtD
Etoricoxib—Anxiety—Donepezil—Alzheimer's disease	0.000199	0.00107	CcSEcCtD
Etoricoxib—Anaemia—Memantine—Alzheimer's disease	0.000196	0.00106	CcSEcCtD
Etoricoxib—Vision blurred—Rivastigmine—Alzheimer's disease	0.000196	0.00106	CcSEcCtD
Etoricoxib—Agitation—Memantine—Alzheimer's disease	0.000195	0.00105	CcSEcCtD
Etoricoxib—CYP3A4—nervous system—Alzheimer's disease	0.000195	0.0123	CbGeAlD
Etoricoxib—Dry mouth—Donepezil—Alzheimer's disease	0.000195	0.00105	CcSEcCtD
Etoricoxib—Abdominal pain—Galantamine—Alzheimer's disease	0.000195	0.00105	CcSEcCtD
Etoricoxib—Tremor—Rivastigmine—Alzheimer's disease	0.000195	0.00105	CcSEcCtD
Etoricoxib—Confusional state—Donepezil—Alzheimer's disease	0.000193	0.00104	CcSEcCtD
Etoricoxib—Anaemia—Rivastigmine—Alzheimer's disease	0.000192	0.00103	CcSEcCtD
Etoricoxib—CYP2D6—nervous system—Alzheimer's disease	0.000192	0.0121	CbGeAlD
Etoricoxib—Agitation—Rivastigmine—Alzheimer's disease	0.000191	0.00103	CcSEcCtD
Etoricoxib—Oedema—Donepezil—Alzheimer's disease	0.000191	0.00103	CcSEcCtD
Etoricoxib—Infection—Donepezil—Alzheimer's disease	0.00019	0.00102	CcSEcCtD
Etoricoxib—Shock—Donepezil—Alzheimer's disease	0.000188	0.00101	CcSEcCtD
Etoricoxib—Palpitations—Memantine—Alzheimer's disease	0.000188	0.00101	CcSEcCtD
Etoricoxib—CYP3A4—central nervous system—Alzheimer's disease	0.000188	0.0119	CbGeAlD
Etoricoxib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000187	0.00101	CcSEcCtD
Etoricoxib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000187	0.00101	CcSEcCtD
Etoricoxib—Cough—Memantine—Alzheimer's disease	0.000185	0.000999	CcSEcCtD
Etoricoxib—CYP2E1—brain—Alzheimer's disease	0.000185	0.0117	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—Alzheimer's disease	0.000185	0.0117	CbGeAlD
Etoricoxib—Palpitations—Rivastigmine—Alzheimer's disease	0.000184	0.000989	CcSEcCtD
Etoricoxib—Hypertension—Memantine—Alzheimer's disease	0.000183	0.000988	CcSEcCtD
Etoricoxib—Anorexia—Donepezil—Alzheimer's disease	0.000182	0.00098	CcSEcCtD
Etoricoxib—Hypersensitivity—Galantamine—Alzheimer's disease	0.000182	0.000978	CcSEcCtD
Etoricoxib—Cough—Rivastigmine—Alzheimer's disease	0.000181	0.000977	CcSEcCtD
Etoricoxib—Arthralgia—Memantine—Alzheimer's disease	0.000181	0.000974	CcSEcCtD
Etoricoxib—Chest pain—Memantine—Alzheimer's disease	0.000181	0.000974	CcSEcCtD
Etoricoxib—CYP2D6—cerebellum—Alzheimer's disease	0.000181	0.0114	CbGeAlD
Etoricoxib—Anxiety—Memantine—Alzheimer's disease	0.00018	0.000971	CcSEcCtD
Etoricoxib—Hypertension—Rivastigmine—Alzheimer's disease	0.000179	0.000967	CcSEcCtD
Etoricoxib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000177	0.000953	CcSEcCtD
Etoricoxib—Chest pain—Rivastigmine—Alzheimer's disease	0.000177	0.000953	CcSEcCtD
Etoricoxib—Dry mouth—Memantine—Alzheimer's disease	0.000177	0.000953	CcSEcCtD
Etoricoxib—Asthenia—Galantamine—Alzheimer's disease	0.000177	0.000952	CcSEcCtD
Etoricoxib—Anxiety—Rivastigmine—Alzheimer's disease	0.000176	0.00095	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000176	0.000947	CcSEcCtD
Etoricoxib—Confusional state—Memantine—Alzheimer's disease	0.000175	0.000942	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000174	0.000937	CcSEcCtD
Etoricoxib—Oedema—Memantine—Alzheimer's disease	0.000173	0.000934	CcSEcCtD
Etoricoxib—Dry mouth—Rivastigmine—Alzheimer's disease	0.000173	0.000932	CcSEcCtD
Etoricoxib—Insomnia—Donepezil—Alzheimer's disease	0.000173	0.00093	CcSEcCtD
Etoricoxib—Infection—Memantine—Alzheimer's disease	0.000172	0.000928	CcSEcCtD
Etoricoxib—Confusional state—Rivastigmine—Alzheimer's disease	0.000171	0.000921	CcSEcCtD
Etoricoxib—Shock—Memantine—Alzheimer's disease	0.000171	0.000919	CcSEcCtD
Etoricoxib—PTGS2—brain—Alzheimer's disease	0.000171	0.0108	CbGeAlD
Etoricoxib—Dyspnoea—Donepezil—Alzheimer's disease	0.00017	0.000917	CcSEcCtD
Etoricoxib—Nervous system disorder—Memantine—Alzheimer's disease	0.00017	0.000916	CcSEcCtD
Etoricoxib—Somnolence—Donepezil—Alzheimer's disease	0.00017	0.000914	CcSEcCtD
Etoricoxib—Thrombocytopenia—Memantine—Alzheimer's disease	0.00017	0.000914	CcSEcCtD
Etoricoxib—Oedema—Rivastigmine—Alzheimer's disease	0.00017	0.000914	CcSEcCtD
Etoricoxib—Diarrhoea—Galantamine—Alzheimer's disease	0.000169	0.000908	CcSEcCtD
Etoricoxib—Infection—Rivastigmine—Alzheimer's disease	0.000169	0.000908	CcSEcCtD
Etoricoxib—Skin disorder—Memantine—Alzheimer's disease	0.000168	0.000907	CcSEcCtD
Etoricoxib—Dyspepsia—Donepezil—Alzheimer's disease	0.000168	0.000905	CcSEcCtD
Etoricoxib—Shock—Rivastigmine—Alzheimer's disease	0.000167	0.000899	CcSEcCtD
Etoricoxib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000166	0.000896	CcSEcCtD
Etoricoxib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000166	0.000895	CcSEcCtD
Etoricoxib—Decreased appetite—Donepezil—Alzheimer's disease	0.000166	0.000894	CcSEcCtD
Etoricoxib—Anorexia—Memantine—Alzheimer's disease	0.000165	0.00089	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000165	0.000888	CcSEcCtD
Etoricoxib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000165	0.000887	CcSEcCtD
Etoricoxib—Fatigue—Donepezil—Alzheimer's disease	0.000165	0.000887	CcSEcCtD
Etoricoxib—Constipation—Donepezil—Alzheimer's disease	0.000163	0.00088	CcSEcCtD
Etoricoxib—Pain—Donepezil—Alzheimer's disease	0.000163	0.00088	CcSEcCtD
Etoricoxib—Dizziness—Galantamine—Alzheimer's disease	0.000163	0.000878	CcSEcCtD
Etoricoxib—Anorexia—Rivastigmine—Alzheimer's disease	0.000162	0.000871	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000158	0.000851	CcSEcCtD
Etoricoxib—Feeling abnormal—Donepezil—Alzheimer's disease	0.000157	0.000848	CcSEcCtD
Etoricoxib—Insomnia—Memantine—Alzheimer's disease	0.000157	0.000845	CcSEcCtD
Etoricoxib—Vomiting—Galantamine—Alzheimer's disease	0.000157	0.000844	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000156	0.000841	CcSEcCtD
Etoricoxib—Rash—Galantamine—Alzheimer's disease	0.000155	0.000837	CcSEcCtD
Etoricoxib—Dermatitis—Galantamine—Alzheimer's disease	0.000155	0.000836	CcSEcCtD
Etoricoxib—Dyspnoea—Memantine—Alzheimer's disease	0.000155	0.000833	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000155	0.000832	CcSEcCtD
Etoricoxib—Headache—Galantamine—Alzheimer's disease	0.000154	0.000831	CcSEcCtD
Etoricoxib—Somnolence—Memantine—Alzheimer's disease	0.000154	0.00083	CcSEcCtD
Etoricoxib—Insomnia—Rivastigmine—Alzheimer's disease	0.000153	0.000826	CcSEcCtD
Etoricoxib—Dyspepsia—Memantine—Alzheimer's disease	0.000153	0.000822	CcSEcCtD
Etoricoxib—Urticaria—Donepezil—Alzheimer's disease	0.000152	0.000817	CcSEcCtD
Etoricoxib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000151	0.000815	CcSEcCtD
Etoricoxib—Abdominal pain—Donepezil—Alzheimer's disease	0.000151	0.000813	CcSEcCtD
Etoricoxib—Somnolence—Rivastigmine—Alzheimer's disease	0.000151	0.000812	CcSEcCtD
Etoricoxib—Decreased appetite—Memantine—Alzheimer's disease	0.000151	0.000812	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00015	0.000806	CcSEcCtD
Etoricoxib—Fatigue—Memantine—Alzheimer's disease	0.000149	0.000805	CcSEcCtD
Etoricoxib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000149	0.000804	CcSEcCtD
Etoricoxib—Constipation—Memantine—Alzheimer's disease	0.000148	0.000799	CcSEcCtD
Etoricoxib—Pain—Memantine—Alzheimer's disease	0.000148	0.000799	CcSEcCtD
Etoricoxib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000147	0.000794	CcSEcCtD
Etoricoxib—CYP2D6—brain—Alzheimer's disease	0.000147	0.00927	CbGeAlD
Etoricoxib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000146	0.000789	CcSEcCtD
Etoricoxib—Nausea—Galantamine—Alzheimer's disease	0.000146	0.000788	CcSEcCtD
Etoricoxib—Fatigue—Rivastigmine—Alzheimer's disease	0.000146	0.000788	CcSEcCtD
Etoricoxib—Pain—Rivastigmine—Alzheimer's disease	0.000145	0.000781	CcSEcCtD
Etoricoxib—Constipation—Rivastigmine—Alzheimer's disease	0.000145	0.000781	CcSEcCtD
Etoricoxib—Feeling abnormal—Memantine—Alzheimer's disease	0.000143	0.00077	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000142	0.000764	CcSEcCtD
Etoricoxib—Hypersensitivity—Donepezil—Alzheimer's disease	0.000141	0.000758	CcSEcCtD
Etoricoxib—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00014	0.000753	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000139	0.000747	CcSEcCtD
Etoricoxib—Urticaria—Memantine—Alzheimer's disease	0.000138	0.000742	CcSEcCtD
Etoricoxib—Abdominal pain—Memantine—Alzheimer's disease	0.000137	0.000738	CcSEcCtD
Etoricoxib—Asthenia—Donepezil—Alzheimer's disease	0.000137	0.000738	CcSEcCtD
Etoricoxib—Pruritus—Donepezil—Alzheimer's disease	0.000135	0.000728	CcSEcCtD
Etoricoxib—Urticaria—Rivastigmine—Alzheimer's disease	0.000135	0.000726	CcSEcCtD
Etoricoxib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000134	0.000722	CcSEcCtD
Etoricoxib—Diarrhoea—Donepezil—Alzheimer's disease	0.000131	0.000704	CcSEcCtD
Etoricoxib—Hypersensitivity—Memantine—Alzheimer's disease	0.000128	0.000688	CcSEcCtD
Etoricoxib—Dizziness—Donepezil—Alzheimer's disease	0.000126	0.00068	CcSEcCtD
Etoricoxib—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000125	0.000673	CcSEcCtD
Etoricoxib—Asthenia—Memantine—Alzheimer's disease	0.000124	0.00067	CcSEcCtD
Etoricoxib—Pruritus—Memantine—Alzheimer's disease	0.000123	0.000661	CcSEcCtD
Etoricoxib—Asthenia—Rivastigmine—Alzheimer's disease	0.000122	0.000656	CcSEcCtD
Etoricoxib—Vomiting—Donepezil—Alzheimer's disease	0.000121	0.000654	CcSEcCtD
Etoricoxib—Rash—Donepezil—Alzheimer's disease	0.00012	0.000649	CcSEcCtD
Etoricoxib—Dermatitis—Donepezil—Alzheimer's disease	0.00012	0.000648	CcSEcCtD
Etoricoxib—Pruritus—Rivastigmine—Alzheimer's disease	0.00012	0.000646	CcSEcCtD
Etoricoxib—Headache—Donepezil—Alzheimer's disease	0.00012	0.000644	CcSEcCtD
Etoricoxib—Diarrhoea—Memantine—Alzheimer's disease	0.000119	0.000639	CcSEcCtD
Etoricoxib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000116	0.000625	CcSEcCtD
Etoricoxib—Dizziness—Memantine—Alzheimer's disease	0.000115	0.000618	CcSEcCtD
Etoricoxib—Nausea—Donepezil—Alzheimer's disease	0.000113	0.000611	CcSEcCtD
Etoricoxib—Dizziness—Rivastigmine—Alzheimer's disease	0.000112	0.000604	CcSEcCtD
Etoricoxib—Vomiting—Memantine—Alzheimer's disease	0.00011	0.000594	CcSEcCtD
Etoricoxib—Rash—Memantine—Alzheimer's disease	0.000109	0.000589	CcSEcCtD
Etoricoxib—Dermatitis—Memantine—Alzheimer's disease	0.000109	0.000588	CcSEcCtD
Etoricoxib—Headache—Memantine—Alzheimer's disease	0.000109	0.000585	CcSEcCtD
Etoricoxib—Vomiting—Rivastigmine—Alzheimer's disease	0.000108	0.000581	CcSEcCtD
Etoricoxib—Rash—Rivastigmine—Alzheimer's disease	0.000107	0.000576	CcSEcCtD
Etoricoxib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000107	0.000576	CcSEcCtD
Etoricoxib—Headache—Rivastigmine—Alzheimer's disease	0.000106	0.000572	CcSEcCtD
Etoricoxib—Nausea—Memantine—Alzheimer's disease	0.000103	0.000555	CcSEcCtD
Etoricoxib—Nausea—Rivastigmine—Alzheimer's disease	0.000101	0.000543	CcSEcCtD
Etoricoxib—MAPK14—Gene Expression—ESR1—Alzheimer's disease	1.08e-05	0.00011	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGFR—Alzheimer's disease	1.07e-05	0.000109	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—Alzheimer's disease	1.07e-05	0.000109	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.07e-05	0.000109	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.06e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.05e-05	0.000107	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADAM10—Alzheimer's disease	1.05e-05	0.000107	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH1—Alzheimer's disease	1.04e-05	0.000106	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.04e-05	0.000106	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—Alzheimer's disease	1.02e-05	0.000104	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.01e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.01e-05	0.000102	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1e-05	0.000102	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ENO1—Alzheimer's disease	1e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	9.95e-06	0.000101	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.94e-06	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—S100B—Alzheimer's disease	9.91e-06	0.000101	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	9.82e-06	9.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—Alzheimer's disease	9.82e-06	9.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—GSK3B—Alzheimer's disease	9.82e-06	9.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CREB1—Alzheimer's disease	9.74e-06	9.91e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.67e-06	9.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MAOB—Alzheimer's disease	9.6e-06	9.76e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADAM10—Alzheimer's disease	9.56e-06	9.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF2—Alzheimer's disease	9.44e-06	9.6e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	9.43e-06	9.59e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ENO1—Alzheimer's disease	9.43e-06	9.59e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.34e-06	9.5e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.33e-06	9.49e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BCHE—Alzheimer's disease	9.31e-06	9.47e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	9.25e-06	9.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	9.24e-06	9.4e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.21e-06	9.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.21e-06	9.37e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.14e-06	9.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.13e-06	9.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.13e-06	9.29e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—Alzheimer's disease	9.12e-06	9.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.05e-06	9.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—A2M—Alzheimer's disease	8.92e-06	9.08e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.83e-06	8.98e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—Alzheimer's disease	8.82e-06	8.97e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PLCB1—Alzheimer's disease	8.79e-06	8.94e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BCHE—Alzheimer's disease	8.77e-06	8.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MAOB—Alzheimer's disease	8.75e-06	8.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LPL—Alzheimer's disease	8.75e-06	8.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MEF2C—Alzheimer's disease	8.67e-06	8.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCA1—Alzheimer's disease	8.52e-06	8.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKCG—Alzheimer's disease	8.51e-06	8.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.5e-06	8.65e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.49e-06	8.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	8.43e-06	8.57e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.33e-06	8.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGF—Alzheimer's disease	8.29e-06	8.43e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	8.27e-06	8.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.25e-06	8.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—Alzheimer's disease	8.23e-06	8.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.21e-06	8.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BCL2—Alzheimer's disease	8.18e-06	8.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.14e-06	8.28e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—Alzheimer's disease	8.06e-06	8.2e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	8.02e-06	8.16e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—LPL—Alzheimer's disease	7.98e-06	8.12e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.96e-06	8.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2A—Alzheimer's disease	7.89e-06	8.02e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CHAT—Alzheimer's disease	7.8e-06	7.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TPI1—Alzheimer's disease	7.8e-06	7.94e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ACHE—Alzheimer's disease	7.76e-06	7.9e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRKCG—Alzheimer's disease	7.76e-06	7.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	7.67e-06	7.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—Alzheimer's disease	7.59e-06	7.72e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MAOB—Alzheimer's disease	7.48e-06	7.61e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—Alzheimer's disease	7.45e-06	7.58e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALM1—Alzheimer's disease	7.36e-06	7.49e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—Alzheimer's disease	7.35e-06	7.48e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	7.34e-06	7.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—Alzheimer's disease	7.33e-06	7.46e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOE—Alzheimer's disease	7.33e-06	7.46e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HMOX1—Alzheimer's disease	7.31e-06	7.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO1—Alzheimer's disease	7.27e-06	7.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	7.27e-06	7.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—Alzheimer's disease	7.27e-06	7.39e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CAV1—Alzheimer's disease	7.26e-06	7.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.26e-06	7.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—Alzheimer's disease	7.23e-06	7.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	7.2e-06	7.32e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—Alzheimer's disease	7.19e-06	7.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.14e-06	7.26e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	7.13e-06	7.26e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.12e-06	7.24e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.08e-06	7.2e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.06e-06	7.18e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.05e-06	7.17e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ESR1—Alzheimer's disease	7e-06	7.12e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7e-06	7.12e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—A2M—Alzheimer's disease	6.95e-06	7.07e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—F2—Alzheimer's disease	6.91e-06	7.03e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	6.91e-06	7.03e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	6.88e-06	7e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH1—Alzheimer's disease	6.77e-06	6.88e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BCHE—Alzheimer's disease	6.76e-06	6.88e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CALM1—Alzheimer's disease	6.71e-06	6.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—AKT1—Alzheimer's disease	6.71e-06	6.82e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.69e-06	6.81e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.69e-06	6.81e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOE—Alzheimer's disease	6.69e-06	6.8e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—LPL—Alzheimer's disease	6.68e-06	6.8e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO1—Alzheimer's disease	6.63e-06	6.75e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	6.63e-06	6.75e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK8—Alzheimer's disease	6.63e-06	6.74e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CAV1—Alzheimer's disease	6.63e-06	6.74e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.51e-06	6.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6.38e-06	6.49e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GSK3B—Alzheimer's disease	6.35e-06	6.46e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CREB1—Alzheimer's disease	6.3e-06	6.41e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—LPL—Alzheimer's disease	6.29e-06	6.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—INS—Alzheimer's disease	6.26e-06	6.37e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.26e-06	6.37e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—Alzheimer's disease	6.23e-06	6.34e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.22e-06	6.33e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.2e-06	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.19e-06	6.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOTCH1—Alzheimer's disease	6.17e-06	6.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.17e-06	6.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—Alzheimer's disease	6.16e-06	6.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—Alzheimer's disease	6.06e-06	6.16e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ACHE—Alzheimer's disease	6.05e-06	6.15e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.02e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.02e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—Alzheimer's disease	6.02e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	5.98e-06	6.08e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.87e-06	5.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	5.82e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GSK3B—Alzheimer's disease	5.79e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.77e-06	5.87e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CREB1—Alzheimer's disease	5.75e-06	5.85e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—INS—Alzheimer's disease	5.71e-06	5.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.71e-06	5.81e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.69e-06	5.79e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO1—Alzheimer's disease	5.67e-06	5.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	5.67e-06	5.77e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	5.66e-06	5.76e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	5.64e-06	5.74e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CALM1—Alzheimer's disease	5.62e-06	5.72e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—Alzheimer's disease	5.6e-06	5.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.56e-06	5.65e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.56e-06	5.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CAV1—Alzheimer's disease	5.55e-06	5.65e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—Alzheimer's disease	5.49e-06	5.59e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.37e-06	5.46e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.33e-06	5.42e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.31e-06	5.4e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CALM1—Alzheimer's disease	5.29e-06	5.38e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—Alzheimer's disease	5.27e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BCHE—Alzheimer's disease	5.27e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAV1—Alzheimer's disease	5.23e-06	5.32e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—Alzheimer's disease	5.01e-06	5.1e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.97e-06	5.06e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.9e-06	4.99e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.88e-06	4.97e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—Alzheimer's disease	4.88e-06	4.96e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.88e-06	4.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.86e-06	4.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.85e-06	4.94e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.84e-06	4.92e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.82e-06	4.9e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INS—Alzheimer's disease	4.79e-06	4.87e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.67e-06	4.75e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—Alzheimer's disease	4.66e-06	4.74e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.61e-06	4.69e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—Alzheimer's disease	4.59e-06	4.67e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INS—Alzheimer's disease	4.51e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.46e-06	4.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.43e-06	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.37e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.37e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.37e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.29e-06	4.36e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—Alzheimer's disease	4.29e-06	4.36e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—Alzheimer's disease	4.23e-06	4.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—Alzheimer's disease	4.2e-06	4.27e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.15e-06	4.23e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.14e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.08e-06	4.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.07e-06	4.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.07e-06	4.14e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.03e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.02e-06	4.09e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.98e-06	4.05e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—Alzheimer's disease	3.96e-06	4.03e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.95e-06	4.02e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—Alzheimer's disease	3.91e-06	3.97e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—Alzheimer's disease	3.88e-06	3.95e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.84e-06	3.9e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.78e-06	3.85e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.76e-06	3.82e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.74e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.72e-06	3.79e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.72e-06	3.78e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.71e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.71e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.68e-06	3.74e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—Alzheimer's disease	3.63e-06	3.7e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.61e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.54e-06	3.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INS—Alzheimer's disease	3.48e-06	3.54e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.41e-06	3.46e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—Alzheimer's disease	3.31e-06	3.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.26e-06	3.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.23e-06	3.29e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.21e-06	3.26e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INS—Alzheimer's disease	3.2e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.19e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.18e-06	3.24e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.17e-06	3.22e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INS—Alzheimer's disease	3.17e-06	3.22e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.14e-06	3.2e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.05e-06	3.1e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—Alzheimer's disease	2.99e-06	3.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.92e-06	2.97e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.8e-06	2.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.79e-06	2.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.78e-06	2.83e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.76e-06	2.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—Alzheimer's disease	2.74e-06	2.78e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INS—Alzheimer's disease	2.71e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.63e-06	2.67e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.56e-06	2.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.54e-06	2.59e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—Alzheimer's disease	2.53e-06	2.57e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—Alzheimer's disease	2.5e-06	2.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.46e-06	2.5e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.45e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.42e-06	2.47e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.38e-06	2.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—Alzheimer's disease	2.3e-06	2.34e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.17e-06	2.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.13e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INS—Alzheimer's disease	2.09e-06	2.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—Alzheimer's disease	1.93e-06	1.96e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.83e-06	1.86e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.82e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.68e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.4e-06	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.29e-06	1.31e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.28e-06	1.3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.09e-06	1.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.43e-07	8.57e-06	CbGpPWpGaD
